TrustLinq launches Swiss-regulated, non-custodial bridge to spend crypto as fiat across 70+ currencies

Published: 2025-12-09 08:16:36 |

TrustLinq, a Swiss-regulated payments intermediary, has launched a non-custodial infrastructure that lets crypto holders fund fiat-denominated payments and settle in more than 70 currencies via established rails (SEPA, SWIFT, Faster Payments, ACH and others) without requiring a bank account. At launch the service supports USDT (ERC20, TRC20), USDC and EURC, with plans for additional integrations, settlement routes and debit-card solutions. Operating under Swiss regulation and AML controls, TrustLinq positions its model as “Self-Custodial Crypto to Third-Party Fiat Settlement”: users retain private-key control while the platform facilitates fiat payouts through multi-jurisdiction settlement connectivity and structured operational controls. The company emphasises secure, non-custodial asset-handling and is initially available in eligible jurisdictions. The announcement is a sponsored press release and not investment advice.

Neutral

This announcement is functionally positive for crypto usability but is unlikely to move prices of the tokens mentioned (USDT, USDC, EURC) materially. TrustLinq expands on-ramps/off-ramps and merchant settlement options — improving utility and potential transaction volumes — but it is not a new protocol token, exchange listing, or major liquidity event that typically drives price action. Stablecoins like USDT and USDC are pegged to fiat; added settlement rails may increase usage and transaction throughput, which supports broader adoption but does not create intrinsic upward price pressure. Short-term: limited price reaction expected due to stablecoin peg mechanics and the infrastructural (non-speculative) nature of the product. Long-term: incremental bullish for ecosystem usability and fiat-crypto flow, potentially increasing transaction volume and demand for on-chain settlement services, but impact on stablecoin price remains neutral. Market risks include regulatory constraints in certain jurisdictions and execution/rollout delays that could limit uptake.